Life ScienceCompany
Galapagos M&A Summary
Galapagos has acquired 9 companies, including 2 in the last 5 years. It has also divested 4 assets.
Galapagos’ largest acquisition to date was in 2008, when it acquired Sareum Holdings - Drug Discovery business for $783M. It’s largest disclosed sale occurred in 2014, when it sold Galapagos NV - CRO Services Division to Charles River Laboratories International for $145M. Galapagos has acquired in 2 different US states, and 5 countries. The Company’s most targeted sectors include life science (89%) and information technology (12%).
Galapagos Business Overview
Where is Galapagos headquartered?
Galapagos is headquartered in Mechelen, Belgium.
What is Galapagos’ revenue?
Galapagos disclosed revenue of 478M EUR for 2020 and 845M EUR for 2019.
How many employees does Galapagos have?
Galapagos has 1,397 employees.
What sector is Galapagos in?
Galapagos is a life science company.
When was Galapagos founded?
Galapagos was founded in 1999.
M&A Summary
-
M&A Total Activity13
- M&A Buy Activity9
- M&A Sell Activity4
- Total Sectors Invested 2
- Total Countries Invested 5
- M&A Buy/Sell Connections 6
Unlimited Searches
